DK112796B - Fremstilling af 11β-hydroxy-3-oxo-13-alkyl-Δ<4,9>-gonadiener. - Google Patents

Fremstilling af 11β-hydroxy-3-oxo-13-alkyl-Δ<4,9>-gonadiener.

Info

Publication number
DK112796B
DK112796B DK289764AA DK289764A DK112796B DK 112796 B DK112796 B DK 112796B DK 289764A A DK289764A A DK 289764AA DK 289764 A DK289764 A DK 289764A DK 112796 B DK112796 B DK 112796B
Authority
DK
Denmark
Prior art keywords
gonadienes
oxo
hydroxy
alkyl
preparation
Prior art date
Application number
DK289764AA
Other languages
Danish (da)
English (en)
Inventor
J Jolly
R Joly
J Warnant
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of DK112796B publication Critical patent/DK112796B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK289764AA 1963-07-10 1964-06-10 Fremstilling af 11β-hydroxy-3-oxo-13-alkyl-Δ<4,9>-gonadiener. DK112796B (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR941004A FR1375078A (fr) 1963-07-10 1963-07-10 Procédé d'introduction d'une fonction oxygénée en position 11 de certains 19-norstéroïdes et produits en résultant
FR951379A FR1468639A (fr) 1963-07-10 1963-10-22 Nouveau stéroïde diénique 11-oxygéné et procédé de préparation
FR960726A FR5089M (fr) 1963-07-10 1964-01-17
FR971005A FR3845M (fr) 1963-07-10 1964-04-15 Nouveau médicament notamment pour le traitement de l'hypercholestérolémie et des troubles en résultant.

Publications (1)

Publication Number Publication Date
DK112796B true DK112796B (da) 1969-01-20

Family

ID=27445615

Family Applications (2)

Application Number Title Priority Date Filing Date
DK289764AA DK112796B (da) 1963-07-10 1964-06-10 Fremstilling af 11β-hydroxy-3-oxo-13-alkyl-Δ<4,9>-gonadiener.
DK289864AA DK119107B (da) 1963-07-10 1964-06-10 Fremgangsmåde til fremstilling af 11β-hydroperoxy-3-oxo-13-alkyl-Δ<4,9>-gonadiener.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK289864AA DK119107B (da) 1963-07-10 1964-06-10 Fremgangsmåde til fremstilling af 11β-hydroperoxy-3-oxo-13-alkyl-Δ<4,9>-gonadiener.

Country Status (10)

Country Link
US (2) US3301756A (fr)
BE (2) BE649224A (fr)
BR (2) BR6459890D0 (fr)
CH (2) CH432504A (fr)
DE (2) DE1232577B (fr)
DK (2) DK112796B (fr)
FR (4) FR1375078A (fr)
GB (3) GB1074495A (fr)
NL (3) NL6406712A (fr)
SE (2) SE316170B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL123455C (fr) * 1964-05-13
US3389153A (en) * 1965-08-13 1968-06-18 Merck & Co Inc 3-enol ethers of 17alpha-haloethynyl-estra 3, 5(10), 9(11)-trien-17beta-ols
FR205F (fr) * 1965-10-22
NL129874C (fr) * 1966-03-15
US3475469A (en) * 1967-06-27 1969-10-28 American Home Prod 13 - alkyl - 9 - chloromethylgon - 4-en-17beta-ol-3-ones and intermediates therefor
CN101208369B (zh) * 2005-06-28 2013-03-27 E.I.内穆尔杜邦公司 高功函数透明导体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3211764A (en) * 1963-09-25 1965-10-12 American Cyanamid Co 19-norandrostadienes and method of preparing the same

Also Published As

Publication number Publication date
GB1074492A (en) 1967-07-05
CH432504A (fr) 1967-03-31
NL6406711A (fr) 1965-01-11
BE649223A (fr)
GB1074491A (en) 1967-07-05
US3301756A (en) 1967-01-31
GB1074495A (en) 1967-07-05
NL6406712A (fr) 1965-01-11
FR5089M (fr) 1967-05-22
DE1232577B (de) 1967-01-19
SE316172B (fr) 1969-10-20
SE316170B (fr) 1969-10-20
FR1375078A (fr) 1964-10-16
NL121957C (fr)
FR3845M (fr) 1966-01-17
BR6459891D0 (pt) 1973-09-11
DE1229526B (de) 1966-12-01
CH433276A (fr) 1967-04-15
US3282785A (en) 1966-11-01
BE649224A (fr)
DK119107B (da) 1970-11-16
FR1468639A (fr) 1967-02-10
BR6459890D0 (pt) 1973-08-09

Similar Documents

Publication Publication Date Title
DK116205B (da) Analogifremgangsmåde til fremstilling af 17α-alkanoyloxy-9α-halogen-16β-methyl-11β,21-dihydroxy-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.
DK106552C (da) Fremgangsmåde til fremstilling af substituerede 6,7-benzomorphaner.
DK108500C (da) Fremgangsmåde til fremstilling af 1-glykosyl-5-azacytosiner.
DK111956B (da) Fremgangsmåde til fremstilling af 3,5-dioxo-17β-hydroxy-4,5-seco-Δ&lt;9&gt;-estren.
DK117957B (da) Fremgangsmåde til fremstilling af 13β-alkyl-3-oxogona-4,9,11-triener.
DK112796B (da) Fremstilling af 11β-hydroxy-3-oxo-13-alkyl-Δ&lt;4,9&gt;-gonadiener.
DK106185C (da) Fremgangsmåde til fremstilling af 17α-acyloxy-4,6-pregnadien-20-oner.
DK104461C (da) Fremgangsmåde til fremstilling af 3-amino-isoxazoler.
DK105592C (da) Fremgangsmåde til fremstilling af substituerede 5-fluor-pyrimidiner.
DK121120B (da) Fremgangsmåde til fremstilling af 3-hydroxy-Δ&lt;1,5&gt;-androstadiener eller 3-estere eller 3-ethere deraf.
DK107031C (da) Fremgangsmåde til fremstilling af 2-halogenmethyl-quinazolin-3-oxider.
DK114972B (da) Fremgangsmåde til fremstilling af 4-halogen-1,2α; 6,7β-bismethylen-Δ&lt;4&gt;-3-ketosteroider.
DK104571C (da) Fremgangsmåde til fremstilling af trans-2-phenyl-3-methylmorpholin.
DK106329C (da) Fremgangsmåde til fremstilling af 3,20-dioxo-19-nor-4,9,11-pregnatrien.
DK111487B (da) Fremgangsmåde til fremstilling af 17β-hydroxy- eller 17β-alkanoyloxy-3-keto-Δ&lt;4,8(14),9&gt;-gonatriener.
DK117955B (da) Analogifremgangsmåde til fremstilling af N&lt;4&gt;-acrylerede 1-halogenbenzen-2,4-disulfonamider.
DK109895C (da) Fremgangsmåde til fremstilling af 1,3-dioxo-2-alkyl-cyclopentaner.
DK114904B (da) Fremgangsmåde til fremstilling af 3,5-diiodthyroniner.
DK116368B (da) Fremgangsmåde til fremstilling af 2,3-dihydro-2,2,4-trimethyl-7-benzofuranol.
DK103832C (da) Fremgangsmåde til fremstilling af 4-(N&lt;1&gt;-alkanoylsulfanilamido)-5,6-dimethoxy-pyrimidiner.
DK108153C (da) Fremgangsmåde til fremstilling af 1-alkyl-5-nitroimidazol-2-carboxylater.
DK116206B (da) Fremgangsmåde til fremstilling af 16α-brom- eller -iod-3,20-dioxo-17α-hydroxy-Δ&lt;4&gt;-pregnener.
DK114202B (da) Fremgangsmåde til fremstilling af 5β-H-6-keto-Δ&lt;7&gt;-14α-hydroksysteroider.
DK105983C (da) Fremgangsmåde til fremstilling af 2-alkoxy-5-aryl-3H-1,4-benzodiazepin-4-oxider.
DK103885C (da) Fremgangsmåde til fremstilling af 5-substituerede N&lt;1&gt;-acyl-2-p-aminobenzensulfonamido-pyrimidiner.